MedPath

The COLDICE Trial: Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease allianCE

Not Applicable
Completed
Conditions
Interstitial Lung Disease
Respiratory - Other respiratory disorders / diseases
Registration Number
ACTRN12615000718549
Lead Sponsor
auren Troy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
65
Inclusion Criteria

Patients assessed as requiring histopathology for the diagnosis of their ILD (at specialist multidisciplinary team meetings), and considered suitable for VATS lung biopsy.

Exclusion Criteria

* Age > 80
* Resting oxyhaemoglobin saturation under 90%
* Platelets less than 100
* INR > 1.5
* Advanced comorbidities (including poorly controlled systemic hypertension, congestive cardiac failure, unstable angina, significant stroke).
* History of of adverse reaction to general anaesthesia
* Inability to provide informed consent
* Systolic pulmonary artery pressure over 40mmHg on echocardiogram or evidence of right ventricular dysfunction
* Inability to withhold anti-platelet therapy (eg aspirin or clopidogrel)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath